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Abstract
Discriminating self and non-self is a universal requirement of immune systems. Adaptive immune systems in prokaryotes are
centered around repetitive loci called CRISPRs (clustered regularly interspaced short palindromic repeat), into which invader
DNA fragments are incorporated. CRISPR transcripts are processed into small RNAs that guide CRISPR-associated (Cas)
proteins to invading nucleic acids by complementary base pairing. However, to avoid autoimmunity it is essential that these
RNA-guides exclusively target invading DNA and not complementary DNA sequences (i.e., self-sequences) located in the
host’s own CRISPR locus. Previous work on the Type III-A CRISPR system from Staphylococcus epidermidis has demonstrated
that a portion of the CRISPR RNA-guide sequence is involved in self versus non-self discrimination. This self-avoidance
mechanism relies on sensing base pairing between the RNA-guide and sequences flanking the target DNA. To determine if
the RNA-guide participates in self versus non-self discrimination in the Type I-E system from Escherichia coli we altered base
pairing potential between the RNA-guide and the flanks of DNA targets. Here we demonstrate that Type I-E systems
discriminate self from non-self through a base pairing-independent mechanism that strictly relies on the recognition of four
unchangeable PAM sequences. In addition, this work reveals that the first base pair between the guide RNA and the PAM
nucleotide immediately flanking the target sequence can be disrupted without affecting the interference phenotype.
Remarkably, this indicates that base pairing at this position is not involved in foreign DNA recognition. Results in this paper
reveal that the Type I-E mechanism of avoiding self sequences and preventing autoimmunity is fundamentally different
from that employed by Type III-A systems. We propose the exclusive targeting of PAM-flanked sequences to be termed a
target versus non-target discrimination mechanism.
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Introduction
There are several prokaryotic defense systems that confer
innate immunity against invading mobile genetic elements,
such as receptor masking, blocking DNA injection, restriction/
modification (R-M) and abortive infection (reviewed in [1–3]).
In addition, half of the bacteria, and most of the archaea,
contain CRISPR-Cas (Clustered Regularly Interspaced Short
Palindromic Repeats/CRISPR-associated) defense systems,
unique in being the only adaptive line of prokaryotic defense
(reviewed in [4–7]). CRISPR-Cas systems provide adaptive
immunity to the host by incorporating invader DNA sequences
into chromosomal CRISPR loci [8–11]. The 30–40 nt invad-
er-derived DNA sequences are separated by host-derived
similarly-sized repeat sequences. Adjacent to a CRISPR locus,
a set of cas genes can often be found that encode the protein
machinery essential for CRISPR-immunity. The cas genes
occur in characteristic combinations that serve as a classifica-
tion criterion of CRISPR-Cas systems into three major types
[12]. In Type I and Type III systems the long precursor
CRISPR RNA (pre-crRNA) is processed by CRISPR specific
endoribonucleases into small CRISPR RNAs (crRNAs) that
contain a repeat sequence flaked by portions of the adjacent
CRISPR repeat sequence [13–18]. In some CRISPR-Cas
subtypes the crRNA undergoes further processing at the 39 end
[19,20]. In Type II CRISPR-Cas systems the pre-crRNA is
processed by RNase III [21]. The processed crRNA molecules
then remain bound to one or more Cas proteins to guide
recognition and cleavage of complementary nucleic acid
sequences [22–27].
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With the exception of Type III-B CRISPR-Cas systems, which
cleave RNA [23,24,28], all other characterized CRISPR-Cas
systems appear to target DNA [27,29–32] and hence require a
mechanism to avoid aberrant cleavage of genomic DNA, i.e. a
mechanism to discriminate the genomic ‘‘self’’ DNA of a CRISPR
cassette from the invader ‘‘non-self’’ DNA. The absence of such
discrimination leads to a suicidal autoimmune response [33–35].
In R-M systems this problem is solved by modification of the
genomic DNA and cleavage of unmodified invader DNA only
(reviewed in [3]). For CRISPR-Cas systems on the other hand, the
mechanism(s) of self versus non-self discrimination is only partially
understood.
For the Type III-A system of Staphylococcus epidermidis autoim-
munity is prevented through a mechanism that relies on sensing
base pairing between the 59-handle (the repeat-derived sequence
at the 59-end of the crRNA) and the corresponding portion of
CRISPR repeat [36]. The Type III-A CRISPR-Cas system
consists of nine cas genes (cas1, cas2, cas10, csm2, csm3, csm4, csm5,
csm6, cas6) and a CRISPR with type-8 repeats [37]. After a
primary processing step of the pre-crRNA, the resulting crRNAs
are further matured through ruler-based cleavage from the 39 end,
yielding 43 and 37 nt crRNA species [20]. These mature crRNA
species guide one or more Cas proteins (possibly a Csm-complex)
to target DNA [32], presumably through base pairing between the
crRNA spacer sequence and the complementary protospacer
sequence. However, CRISPR-interference is inhibited when, in
addition to base pairing over the spacer sequence, the 59-handle
also base pairs with the protospacer-flanking sequence of the target
DNA [36]. In this manner, self-targeting of the CRISPR locus is
avoided by default, since self-targeting inevitably leads to full base
pairing of the 59-handle of the crRNA with the CRISPR repeat
sequence from which it is transcribed. In particular, the presence
or absence of base pairing at three positions downstream of the
protospacer (positions 22, 23, and 24 relative to the 39-end of
the protospacer) is decisive in discriminating self from non-self
[36]. The molecular details of how base pairing at positions
downstream of the protospacer are sensed, and whether it involves
Cas proteins, is currently unknown.
Intriguingly, Type I systems contain di- or tri-nucleotide
conserved motifs (protospacer adjacent motifs (PAM)) downstream
of protospacers opposite of the crRNA 59-handle [38–40]
(Figure 1A and 2A). In the Type I-E CRISPR-Cas system, PAM
sequences are recognized by ribonucleoprotein complex Cascade
during target DNA binding [29,41]. The Type I-E system of
Escherichia coli K12 consists of 8 cas genes (cas3, cse1, cse2, cas7, cas5,
cas6e, cas1, cas2) and two CRISPR loci with type-2 repeats [37].
The ribonucleoprotein complex Cascade is composed of a 61 nt
crRNA, and five different Cas proteins in an uneven stoichiom-
etry: Cse11Cse22Cas76Cas51Cas6e1 [22]. Cascade efficiently binds
target DNA through an R-loop formed between the 32 nt spacer
sequence of the crRNA and the protospacer sequence [22]
(Figure 1A), with a binding affinity that is strongly dependent on
the presence of one of the four functional PAM sequences [29,41].
Whereas R-loop formation by Cascade involves the entire
protospacer sequence [22], it is unknown whether the PAM
nucleotides can participate in base pairing with the crRNA and, if
so, how this influences CRISPR interference. Due to the fact that
the last nucleotide from the repeat is derived from the PAM
sequence during spacer acquisition [8,11,42], this nucleotide in the
crRNA invariably has the potential to base pair with the 21
position of the PAM, and therefore might be involved in R-loop
formation [8]. In contrast, the 22 and 23 positions of the PAM
lack base pairing potential with the 59-handle of the crRNA
(Figure 2A). The 59-handles of other Type I systems and 39-
handles of Type II also display limited base pairing potential with
their cognate PAMs (Table S1), in principle allowing for a
differential base pairing mechanism that defines self versus non-
self. For Type I-F CRISPR-Cas systems, potential base pairing
between PAM sequences and the 59-handle of the crRNA was
recently shown to affect CRISPR interference [43], suggesting that
self versus non-self discrimination in this subtype may depend both
on sensing PAM identity and on sensing differential base pairing
with the crRNA repeat.
In Type I-E systems it has been shown that a loop structure (L1)
of the Cse1 subunit of Cascade specifically interacts with the PAM
sequence, a process that is thought to destabilize the double-
stranded DNA of the target to allow for strand invasion during R-
loop formation [44]. Since self DNA of the CRISPR locus does
not contain PAM sequences, this mechanism would specifically
direct Cascade to target DNA only. However, the observation that
target DNA containing a PAM mutant triggers Cascade-depen-
dent primed spacer acquisition in vivo suggests that PAM
authentication may not be absolutely required for R-loop
formation [11]. Indeed, negatively supercoiled DNA containing
a protospacer with a mutant PAM can still be bound by Cascade,
albeit with a lower affinity than the same target with wild-type
PAM [29]. In line with this, it was suggested that during phage
infection Cascade can overcome the absence of a bona fide PAM
when Cascade expression levels are high and that the target
flanking sequences could participate in this discrimination event
[44]. This suggests that a differential base pairing mechanism may
play a role in self versus non-self discrimination by Type I-E
CRISPR-Cas systems. In agreement with this, it was suggested
that complementarity between the crRNA repeat and the
protospacer flanking sequence inhibits CRISPR-interference in
the Type I-E system of Streptococcus thermophilus [45]. The
mechanistic basis of such a differential base pairing mechanism
could lie in a perturbation of Cse1-mediated PAM recognition by
base pairing interactions between crRNA repeats and the PAM.
To study whether a differential base pairing mechanism plays a
role in self versus non-self discrimination by the Type I-E system of
E. coli K12, we have systematically mutated both the crRNA
Author Summary
CRISPR loci and their associated genes form a diverse set
of adaptive immune systems that are widespread among
prokaryotes. In these systems, the CRISPR-associated
genes (cas) encode for proteins that capture fragments
of invading DNA and integrate these sequences between
repeat sequences of the host’s CRISPR locus. This
information is used upon re-infection to degrade invader
genomes. Storing invader sequences in host genomes
necessitates a mechanism to differentiate between invader
sequences on invader genomes and invader sequences on
the host genome. CRISPR-Cas of Staphylococcus epidermi-
dis (Type III-A system) is inhibited when invader sequences
are flanked by repeat sequences, and this prevents
targeting of the CRISPR locus on the host genome. Here
we demonstrate that Escherichia coli CRISPR-Cas (Type I-E
system) is not inhibited by repeat sequences. Instead, this
system is specifically activated by the presence of bona fide
Protospacer Adjacent Motifs (PAMs) in the target. PAMs are
conserved sequences adjoining invader sequences on the
invader genome, and these sequences are never adjacent
to invader sequences within host CRISPR loci. PAM
recognition is not affected by base pairing potential of
the target with the crRNA. As such, the Type I-E system
lacks the ability to specifically recognize self DNA.
Type I-E Discriminates Targets from Non-Targets
PLOS Genetics | www.plosgenetics.org 2 September 2013 | Volume 9 | Issue 9 | e1003742
Figure 1. Potential base pairing between the crRNA repeat regions and protospacer flanking regions does not affect CRISPR-
interference. A) Model of the R-loop formed by Cascade during dsDNA binding. B) Cells expressing WT g8-Cascade and Cas3 are resistant to
plasmids containing the CAT PAM adjacent to the g8 protospacer (black bars, transformation efficiency 6.761.56105 cfu/mg DNA for plasmid
pWUR690 and 6.860.96105 cfu/mg DNA for plasmid pWUR688), but are susceptible to plasmid transformation when the g8 protospacer is flanked by
a CGG PAM, which is fully complementary to the 59-handle (red bars, transformation efficiency 4.260.96108 cfu/mg DNA for plasmid pWUR687 and
4.560.86108 cfu/mg DNA for plasmid pWUR689). Transformation efficiency for a control pUC19 plasmid is 6.261.16108 cfu/mg DNA. The histogram
shows the in vitro binding affinity of purified WT g8-Cascade for dsDNA containing the g8 protospacer flanked by sequences with a varying base
pairing potential, as shown on the right. Asterisks indicate that the Kd value is..1000 nM and the error bars represent the standard deviation of the
mean.
doi:10.1371/journal.pgen.1003742.g001
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repeats and the protospacer-flanking sequences and determined
the effects of these mutations and their combinations on CRISPR
interference in vivo and target binding in vitro. The results of our
analysis demonstrate that discrimination of self from non-self by
Type I-E CRISPR-Cas systems occurs through a mechanism that
is independent of base pairing between these sequences. Hence,
the principal mechanism by which Type I-E systems discriminate
self from non-self appears to be solely Cse1-mediated and as such
Figure 2. Base pairing at the21 position is not required for CRISPR-interference. A) Model of the R-loop formed by Cascade during dsDNA
binding. The nucleotide adjacent to the spacer sequence (the 21 position) has the potential to base pair with the first nucleotide of the PAM in the
target strand of the DNA. B) Cells expressing WT g8-Cascade and Cas3 are resistant to M13 phage containing the CAT, CTT, CCT or CTC PAMs adjacent
to the M13 protospacer (white font/black bars, e.o.p.,1024), but not when containing the CGT PAM (red font/red bars, e.o.p. = 1). Note that in the
figure the PAMs are oriented in 39 to 59direction to display base pairing potential with the last three nucleotides of the crRNA repeat. The in vitro
binding affinity of purified WT g8-Cascade for dsDNA containing the g8 protospacer and each of the respective PAM mutants is shown in the
adjacent histogram. C) Assays as in (B) using cells expressing the g8G-1T CRISPR, Cascade and Cas3, show that cells are resistant to M13 phage
containing the CAT, CTT, CCT or CTC PAMs adjacent to the g8 protospacer (white font/black bars), but not when containing the CGT PAM (red font/
red bars). The in vitro binding affinity of purified WT g8G-1T-Cascade for dsDNA containing the g8 protospacer and each of the respective PAM
mutants is shown in the adjacent histogram. In (B) and (C) error bars represent the standard deviation of the mean.
doi:10.1371/journal.pgen.1003742.g002
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is fundamentally different from the differential base pairing
mechanism employed by Type III-A systems. While the mecha-
nism employed by Type III-A is best described as being based on
self-recognition (self versus non-self), the mechanism of Type I-E
systems is instead based on target-recognition (target versus non-
target). While Type III systems can differentiate between targets
and non-targets in the absence of a PAM, Type I-E systems are
fully PAM-dependent and discrimination cannot take place in the
absence of a PAM.
Results
Self versus non-self discrimination by the Type III-A CRISPR-
Cas system of S. epidermidis has been shown to rely on a differential
base pairing mechanism [36]. As a result CRISPR-interference is
specifically inhibited when protospacer sequences are flanked by
CRISPR repeat sequences. To test whether this mechanism also
applies to the Type I-E CRISPR-Cas system of E. coli K12,
CRISPR-interference was tested against targets containing proto-
spacers flanked by CRISPR repeat sequences. For these analyses,
we have cloned the previously described g8 protospacer, from
phage M13 [41], into the pUC19 plasmid and systematically
mutated sequences adjacent to the protospacer. E. coli cells
expressing Cascade, a g8 crRNA and Cas3 are resistant against
transformation by a plasmid in which the g8 protospacer is flanked
by a CAT PAM (Fig. 1B, pWUR690, approximately 1000-fold
lower efficiency of transformation than a control pUC19 plasmid).
In contrast, these cells are susceptible to plasmid transformation by
plasmid pWUR687 in which the g8 protospacer is flanked by
CRISPR repeat sequences (Figure 1B). However, the plasmid
resistant phenotype can be restored by introducing a CAT PAM in
the CRISPR repeat sequence flanking the protospacer
(pWUR688), which alters the base pairing potential only at the
22 and 23 positions (Figure 1B). Plasmid pWUR689, which has
the potential to base pair with g8 crRNA at positions 21, 22 and
23 (protospacer adjacent sequence is CGG) escapes CRISPR-
interference from wild-type g8 crRNA expressing E. coli
(Figure 1B). The observation that protospacer adjacent sequences
complementary to the crRNA at positions 21, 22, and 23 avoid
Cascade targeting suggest that base pairing at these positions may
play a role in self avoidance.
To investigate whether avoidance of targeting is due to
decreased binding affinities of Cascade for protospacers with
mutations at the 21, 22, and 23 positions, we performed
Electrophoretic Mobility Shift Assays using purified g8 crRNA-
loaded Cascade. While high affinity binding could be demonstrat-
ed to dsDNA containing the g8 protospacer flanked by the CAT
PAM (Figure 1B and S1), protospacers flanked by either CRISPR
repeat sequences or a repeat-derived CGG sequence were bound
with low affinity (Figure 1B and S1). This indicates that target
versus non-target discrimination occurs at the level of Cascade
affinity for dsDNA target sequences. Furthermore, the data also
indicate that ‘‘self’’ DNA recognition may occur, as observed in
Type III-A systems, through sensing differential base pairing
between protospacer adjacent sequences and the 59 handle of the
crRNA.
To investigate if base pairing between the three nucleotides
from the 59-handle of the crRNA and the PAM is involved in
discriminating self from non-self DNA we systematically mutated
the corresponding nucleotides in the 59-handle (i.e., 21, 22, and
23), and analyzed how these mutations affect CRISPR-based
immunity against DNA targets flanked by various PAM sequences.
Previously [29], four PAM sequences (CAT, CTT, CCT and
CTC), have been reported to confer immunity on wild-type g8
crRNA expressing E. coli against phage M13 infection in vivo, and
to give rise to high affinity DNA binding by g8 crRNA-bound
Cascade in vitro (Figure 2B and Figure S2A). The last nucleotide of
the 59-handle of the crRNA (the 21 position) invariably has the
potential to base pair with the PAM [8], while the 22 and 23
positions lack such base pairing potential (Figure 2A). The
resulting configuration is distinct from the fully base-paired
configuration that would form if base pairing in this region were
the basis of self versus non-self discrimination.
To analyze whether base pairing at position 21 is required for
CRISPR interference, a mutant CRISPR was constructed,
yielding a g8 crRNA that lacks base pairing potential with the
PAM at this position. This CRISPR, denoted g8G-1T carries a G-
to-T substitution at position 21, within the repeat sequence. SDS-
PAGE analysis of purified Cascade complexes containing either
mutant or WT crRNA shows that these complexes have the same
apparent stoichiometry, thereby confirming the integrity of the
complex (Figure S4A). In addition, isolation of crRNA from these
protein complexes shows that crRNA biogenesis is unaffected by
the introduced mutation (Figure S4B). Interestingly, despite the
absence of base pairing at the 21 position, cells expressing the
mutant crRNA maintain the ability to block infection by M13
phages containing each of the four functional PAM sequences
(Figure 2C). Consistently, high affinity binding by g8G-1T crRNA-
containing Cascade to targets containing the g8 protospacer and
the functional PAM variants was observed (Figure 2C and Figure
S2B). However, as previously observed for the WT g8-crRNA-
Cascade complex [29], a mutation at the 22 position of the PAM
(i.e., CGT) neither confers resistance in vivo (efficiency of plaquing
(e.o.p.) = 1) nor gives rise to high affinity DNA binding in vitro
(Figure 2C, and Figure S2B). This PAM mutant potentially yields
an additional base pair with the 22 position of the 59-handle, both
in the WT g8-crRNA-Cascade and the g8G-1T mutant complex
(Figure 2BC). Hence, it appears that a base pair at position 22
may be the signal that a protospacer is located in ‘‘self’’ DNA and
therefore should not be targeted.
To specifically test the role of base pairing at position 22 in
CRISPR-immunity, we designed a synthetic CRISPR locus
containing a C to A substitution at the 22 position of a CRISPR
locus containing spacer sequences that target the g8 protospacer
from M13 phage. The g8C-2A CRISPR mutation results in a slight
effect on Cascade assembly, as the bands corresponding to Cse1
and Cse2 have modestly lower and higher intensities on an SDS-
PAGE, respectively, as compared to wild-type g8-crRNA-Cascade
(Figure S4). However, g8C-2A CRISPR RNA processing is
unaffected (Figure S4). Importantly, the g8C-2A crRNA-guided
Cascade complex has a slightly reduced affinity (60612 nM) for
dsDNA targets that have a canonical CTT PAM sequence, which
has the potential to base pair at the 22 position of the mutant
crRNA (Figure 3A, white PAM). Despite the potential of the
mutant Cascade complex to establish an additional base pair, a
partially resistant phenotype (e.o.p.,1022) is observed against
phages carrying the canonical PAM (Figure 3A), which is
consistent with the in vitro DNA binding experiments (Figure 3A
and Figure S3A). Targets containing non-canonical PAM
sequences are bound with more reduced affinities by the g8C-2A
crRNA-guide Cascade complex and are not subject to CRISPR-
interference in vivo (Figure 3A). The partial resistant phenotype of
the g8C-2A mutant that is observed in combination with the
canonical PAM indicates that potential base pairing at both
positions21 and22 does not serve as a trigger for a non-targeting
response.
To probe the importance of base pairing at the 23 position, an
additional CRISPR mutant was designed, denoted g8C-3G, which
Type I-E Discriminates Targets from Non-Targets
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carries a C to G mutation at the 23 position of the CRISPR
repeat. Again, complex formation and crRNA biogenesis were
unaffected by the mutation (Figure S4). Although the potential for
base pairing with most PAM sequences remains the same, a
dramatic decrease in both resistance against M13 phage in vivo and
DNA binding by g8C-3G-Cascade in vitro is observed (Figure 3B
and Figure S3B).
The combined results obtained with the three CRISPR
mutants indicate that the repeat sequence itself rather than its
base pairing potential with the protospacer flanking sequence
affects PAM recognition. In order to have a more complete and
unbiased analysis of the effects of adding or removing base
pairing potential at positions 21, 22 and 23, we constructed 26
different PAM sequences adjacent to the g8 protospacer in the
M13 phage genome (Figure 4A, white text on black background).
All phages were viable as judged by their ability to infect host
bacteria lacking the M13-targeting CRISPR (data not shown).
The phages were tested for their ability to infect cells expressing
each of the 21 different g8 crRNAs with mutated repeat
sequences at positions 21, 22 and 23. Northern blot analysis
showed that processing of mutant g8 crRNAs was unaffected
(data not shown). The results reveal that only a small subset of
CRISPR repeat mutants confer full phage resistance, and only in
conjunction with the four previously validated functional PAM
sequences (Fig. 4). When resistance was observed, it was
independent of crRNA-PAM base pairing patterns, but rather
appeared to be constrained by a limited number of allowed
nucleotides at the 21, 22 and 23 positions of the 59-handle, and
a fixed number of PAM sequences.
Many 59-handle mutants show a lack of resistance despite the
presence of a bona fide PAM in the target and irrespective of the
base pairing pattern (Figure S5). Efficient CRISPR-interference
requires the presence of a cytosine at the 22 position of the
crRNA repeat (Figure 4). Substitution of this position to guanidine
Figure 3. Base pairing at the22 and23 positions does not interfere with CRISPR-immunity. A) Cells expressing g8C-2A-Cascade and Cas3
are partially resistant to M13 phage containing the CTT PAM adjacent to the g8 protospacer (white font/grey bar, e.o.p.,1022), but not when
containing the CAT, CCT, CTC or CGT PAM (red font/red bars). Note that in the figure the PAMs are oriented in 39 to 59direction to display base pairing
potential with the last three nucleotides of the crRNA repeat. The in vitro binding affinity of purified WT g8C-2A-Cascade for dsDNA containing the g8
protospacer and each of the respective PAM mutants is shown in the adjacent histogram. B) Assays as in (A) using cells expressing the g8C-3G CRISPR,
Cascade and Cas3, show that cells are not resistant to M13 phage containing the CAT, CTT, CCT, CTC or CGT PAMs adjacent to the g8 protospacer (red
font/red bars). The in vitro binding affinity of purified WT g8C-3G-Cascade for dsDNA containing the M13 protospacer and each of the respective PAM
mutants is shown in the adjacent histogram. Asterisks indicate that the Kd value is ..1000 nM and the error bars represent the standard deviation
of the mean.
doi:10.1371/journal.pgen.1003742.g003
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Figure 4. Synonymous mutations of the crRNA and the PAM do not affect self versus non-self discrimination. A) Infectivity of a library
of M13 phage containing PAM mutants adjacent to the g8 protospacer was tested against cells expressing Cascade, Cas3 and g8 CRISPR containing
mutations at the 21, 22 and 23 nucleotides of the CRISPR repeats. PAM mutations are shown on the left, with the PAM sequences indicated in the
39 to 59 direction. CRISPR repeat mutations at positions 21, 22 and 23 are indicated on the top in the 59 to 39 direction. Underscored sequences
have been tested for binding affinity by EMSA. Base pairing potential between the PAM positions and the repeat is indicated using numbers (0–7)
that correspond to a base pairing pattern that is shown in the panel on the right. A 0 signifies no base pairing, a 1 signifies base pairing at the 23
position, a 2 signifies base pairing at the 22 position, etc. Black circles with white digits indicate resistance against phage infection (e.o.p.,1024),
grey circles indicate partial resistance (e.o.p.,1022) and red digits without circle indicate susceptibility to phage infection (e.o.p. = 1), as determined
by phage spot assays. Letters B, C, D, E indicate combinations shown in detail in the corresponding panels. B) Combination of g8C-3AC-2T CRISPR and
M13 phage with CAT PAM, gives rise to full base pairing and a lack of resistance (red font). C) Combination of g8C-3AC-2T CRISPR and M13 phage with
CTC PAM, gives rise to only base pairing at the 21 position and yields a lack of resistance (red font). D) Combination of g8C-3AC-2A CRISPR and M13
phage with CTT PAM gives rise to full base pairing and a lack of resistance (red font). E) Combination of g8C-3AC-2A CRISPR and M13 phage with CTC
PAM gives rise to only two potential base pairs at the 21 and 22 positions and yields a lack of resistance (red font). Note in (A–E) PAMs are oriented
in 39 to 59direction to display base pairing potential with the last three nucleotides of the crRNA repeat.
doi:10.1371/journal.pgen.1003742.g004
Type I-E Discriminates Targets from Non-Targets
PLOS Genetics | www.plosgenetics.org 7 September 2013 | Volume 9 | Issue 9 | e1003742
or uracil interferes with CRISPR-defense. When this position is
mutated to an adenosine, a partially resistant phenotype is
observed during phage infection in conjunction with the canonical
PAM, which is bound with the highest affinity by Cascade in vitro.
Presumably this high affinity binding can compensate for the
negative effects on DNA binding caused by mutations at the 22
position of the 59-handle, leading to a partially phage resistant
phenotype. Furthermore, CRISPR-mediated phage resistance
requires a cytosine at the 23 position. The most likely explanation
for the fact that some repeat mutants are not tolerated is that the
Cascade subunits involved in binding the 59-handle exhibit a level
of sequence specificity.
Although combinations of fully complementary 59-handles and
protospacer flanking sequences do not lead to phage resistance in
vivo, this appears to be base pairing independent (Figure S5), as
restoring the wild-type base pairing pattern by altering proto-
spacer flanking sequences fails to rescue the phage-sensitive
phenotype. For example, the g8C-3A, C-2T CRISPR fails to
provide resistance either against M13 phage with a fully
complementary CAT PAM (Figure 4B) or against a CTC PAM
mutant phage, which is complementary at the 21 position only
(Figure 4C). A similar result is obtained when g8C-3A, C-2A
CRISPR expressing cells are infected with CTT or CTC PAM
phages (Figure 4D and E), indicating that the repeat sequence
itself is affecting CRISPR-interference in these instances.
Altogether, these data exclude the possibility that the Type I-E
system makes use of a differential base pairing mechanism to
inhibit self-targeting. The finding that the specificity of PAM
recognition is unaffected by its potential to base pair with the 59-
handle is consistent with Cse1 being the only factor involved in
PAM recognition [44].
To rule out the possibility that the specificity of PAM
recognition by g8-Cascade variants depends on the expression
levels of CRISPR-Cas components, the same analyses were
performed with an engineered M13 targeting E. coli strain with
cas genes fused to inducible promoters [12]. When repeat
mutations were introduced into the genomic CRISPR cassette in
this strain, identical results were obtained (Figure S6), showing that
the data described here are expression level independent.
Previous studies on the S. thermophilus Type II-A CRISPR1/Cas
system have revealed differences in PAM specificity and
effectivity in either plasmid or phage interference assays
[30,45]. To test whether the Type I-E CRISPR/Cas system also
displays assay-dependent differences in PAM utilization, we
generated plasmids carrying the g8 protospacer (pG8) flanked by
any of the 26 PAM mutants tested in the phage assays.
Transformation of the pG8 variants into E. coli cells expressing
Cascade, a g8 crRNA and Cas3 show that the four PAMs (CAT,
CTT, CCT, and CTC) that provide interference during phage
infection also affect plasmid transformation (resulting in a more
than 1000-fold decrease in efficiency of transformation (e.o.t.)).
Apart from these four PAMs, a non-consensus TTT PAM also
yields a full resistance phenotype (Figure S7; .1000-fold decrease
in e.o.t.), as has been observed before [8], while M13 phage
carrying this non-consensus TTT PAM sequence escape inter-
ference (Figure 4A). In addition, ten non-consensus PAMs give
rise to a partial resistance phenotype (Figure S7; e.o.t. ,1021 for
CCA, CAA, GAT, CTG, and AGA PAMs; e.o.t. ,1022 for
CTA, GTT, TAT, ATT and TTC PAMs), which is in line with
previously reported partial resistance in S. thermophilus against
transformation with a target plasmids carrying non-consensus
PAMs [30]. The data show that PAM authentication during
CRISPR-based protection is more promiscuous during plasmid
transformation than during phage infection.
Discussion
CRISPR-Cas systems are the only prokaryotic adaptive
immune systems described to date. Although initially thought of
as a single system, we now know that these systems are structurally
and mechanistically diverse. Here we have investigated whether a
differential base pairing mechanism to discriminate self from non-
self, as described for the Type III-A system of S. epidermidis, also
applies to the Type I-E CRISPR-Cas system of E. coli K12. By
systematically mutating the crRNA repeat sequence and the PAM
positions, we demonstrate that this Type I-E system does not
utilize the potential for base pairing between the 59-handle and the
protospacer flanking sequences to avoid self targeting.
The 21 position of crRNA has recently been shown to be
invader-derived and hence invariably has the potential to base pair
with cognate DNA, both in E. coli [8,11,42] and in S. thermophilus
[45,46]. This discovery suggested that base pairing at the 21
position would be critical for target recognition by Cascade, in the
same way that nucleotides in the seed region (nucleotides +1 to +5,
+7 and +8) are essential for target recognition [41]. However, our
results clearly show that base pairing at position 21 is not essential
for CRISPR-interference. It has recently been suggested that the
21 position of the CRISPR repeat could be considered part of the
spacer [42]. However, this does not seem appropriate since this
nucleotide does not appear to be involved in base pairing with the
invading target sequence. The absence of a base pairing
requirement for the 21 position might suggest that this position
is not available for base pairing due to structural constraints.
The 22 position of the crRNA repeat requires the presence of a
cytosine for efficient CRISPR-interference (Figure 4). When this
position is mutated to an adenosine, a partially resistant phenotype
is observed during phage infection in conjunction with the
canonical PAM. Substitution of the 22 position to a guanidine
or uracil renders the CRISPR-interference pathway non-func-
tional. Interestingly, mutation of the 22 position to adenosine
causes an apparent structural alteration of the Cascade complex.
While most subunits are present in the same apparent stoichiom-
etry in the mutant g8C-2A-Cascade as in the wild-type complex, the
Cse1 subunit is underrepresented. This might suggest that Cse1
interacts with the 22 position of the repeat and that interaction
with this base is important for efficient incorporation of Cse1 into
the complex. Like the 22 position, the 23 position requires a
cytosine for CRISPR-mediated phage resistance to be manifested.
However, complex formation is unaffected in g8C-3G-Cascade
(Figure S4A).
The 23, 22 and 21 positions are among the most conserved
bases of type 2 repeats [37]. Although the current resolution of the
Cascade structure does not allow us to confidently pinpoint the
location of the 22 and 23 bases of the 59-handle of the crRNA,
these bases appear to be part of a 59 hook-like structure that is
primarily cradled by the last subunit of the Cas7 hexamer (i.e.,
Cas76) [47]. The arch of the crRNA may position the 59 terminal
nucleotides within bonding distance to residues in loop-1 of Cse1,
which is consistent with the assembly defects reported for L1
mutations [44]. However, the resolution of the current Cascade
structure and absence of density for L1 in the X-ray crystal
structures of Cse1 prevent confident assignment of these interac-
tions. Higher-resolution structures of the Cascade will be critical
for a precise understanding how the crRNA and the Cas proteins
are arranged in this complex.
In some CRISPR systems PAM sequences play an important
role during different stages of CRISPR defense. In the Type I-E
system of E. coli, PAM sequences are recognized by Cas1 and/or
Cas2 during the selection of pre-spacers for integration into the
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CRISPR [9]. PAM motifs allow the CRISPR adaptation
machinery to correctly orient newly acquired spacers into the
CRISPR array [38,48–50]. Interestingly, in Type I-E systems, the
PAM selectivity of the CRISPR-adaptation machinery has co-
evolved with that of the CRISPR-interference machinery, as the
preference for the CTT PAM is observed both during Cas1/Cas2-
dependent spacer integration [9] and during target DNA binding
by Cascade [29]. In contrast, the E. coli I-F integration machinery
appears to select for a PAM that overlaps but differs from the motif
that yields optimal interference levels [43]. In this E. coli I-F
subtype the PAM was found to be a GG motif at the 21 and 22
positions relative to the protospacer, while an overlapping, but
different, motif (GG at the 22 and 23 positions) provided optimal
interference levels [43]. The presence of a G at position 22 was
both required and sufficient for interference. The I-F subtype of
Pectobacterium atrosepticum on the other hand requires a GG motif
immediately flanking the protospacer for interference, and
mutagenesis of the G at position 21 to a T (which potentially
base pairs with the repeat) gives rise to an escape phenotype [35].
Recently, a new nomenclature has been proposed that takes into
account the differences in motif selectivity during spacer integra-
tion and CRISPR-interference [51].
PAMs have been shown to be important for CRISPR
interference in various Type I and Type II CRISPR-Cas subtypes
(e.g. Type I-A systems in S. solfataricus [40], Type I-B in Haloferax
volcanii [39], Type I-E in E. coli [29], Type I-F in P. aeruginosa [52],
E. coli [43] and P. atrosepticum [35], as well as in Type II-A and II-B
systems of Streptococcus pyogenes and S. thermophilus [27,30,50,53,54]).
Recently published x-ray crystal structures of the Cse1 subunit of
Cascade [44,55] have provided detailed insights into the molecular
mechanism of Cascade-mediated recognition of the PAM. The
well-conserved L1 loop of Cse1 was shown to directly interact with
the PAM sequence and to enhance target DNA affinity in the
presence of a bona fide PAM [44]. As such, the Cse1 subunit plays a
crucial role in PAM authentication in Type I-E systems [44]. Our
data indicate that PAM authentication occurs without the
formation of base pairs between the 59 handle of the crRNA
and the PAM.
While Cascade-like complexes appear to be common compo-
nents of Type I systems, the PAM-authenticating protein, Cse1, is
unique to Type I-E systems. This could mean that other Cascade-
like complexes, such as the aCascade (IA-Cascade) [25], IC-
Cascade [17] the as yet unidentified ID-Cascade, and the Csy-
complex (IF-Cascade) [26] may have their own specialized PAM-
sensing proteins. It has been hypothesized that the large subunits
of Type I systems (Cas8a1 and Cas8a2 (Type I-A), Cas8b (Type I-
B), Cas8c (Type I-C), Cas10d (Type I-D), Cse1 (Type I-E), Csy1
(Type I-F)) are homologous to Cas10 proteins associated with the
Type III systems [56], but these predictions await experimental
verification. If these predictions are correct they may suggest that
PAM recognition is carried out by the large subunit of other
CRISPR-Cas subtypes.
Under native-like expression levels, the change in affinity of
Cascade for a target resulting from the presence or absence of a
PAM sequence appears to be sufficient to serve as a robust
mechanism to discriminate non-self target sequences (i.e. proto-
spacers flanked by a PAM) from non-target sequences (i.e.
protospacers without PAM) in vivo [44]. Given the absence of
PAM sequences in the CRISPR array, self DNA automatically
falls into the non-target category and is not subject to interference.
For Type III systems, on the other hand, no PAMs have yet been
found, suggesting that these systems lack PAMs [23,36]. For Type
III-A systems it has been shown that differentiation between self
DNA and non-self DNA relies on sensing differential complemen-
tarity between the 59-handle of the crRNA and the protospacer-
flanking sequence (Figure 5A) [36]. This discrimination mecha-
nism is based on specific recognition of self DNA, and is therefore
best described by the term self versus non-self discrimination
(Figure 5A). Here we demonstrate that self-avoidance by the Type
I-E system does not rely on potential base pairing between crRNA
repeats and protospacer flanking sequence. Therefore, Cascade
lacks the ability to specifically recognize self and relies on specific
target DNA recognition through PAM authentication. We argue
that PAM authentication is a ‘‘target versus non-target’’ discrim-
ination mechanism (Figure 5B), which is fundamentally different
from the ‘‘self versus non-self’’ discrimination mechanism
employed by Type III-A systems. Either mechanism is sufficient
to avoid targeting of the CRISPR locus on the host genome. In
target versus non-target discrimination, self sequences within the
CRISPR locus (i.e. spacers) automatically belong to the non-target
class, since PAM sequences are absent in the CRISPR repeat.
Likewise, in self versus non-self discriminating systems target
sequences fall in the non-self class. It appears likely that PAM-
sensing CRISPR-Cas systems all make use of target versus non-
target discrimination. Unlike Type III systems, discrimination
between targets and non-targets by Type I-E systems cannot take
place in the absence of a PAM.
Both discrimination mechanisms, however, are not mutually
exclusive. The Type I-F system of E. coli LF82 has been speculated
to utilize both target versus non-target discrimination and self
versus non-self discrimination [43], although this hypothesis awaits
experimental verification by testing the effect of crRNA repeat
mutagenesis on CRISPR interference. By having both mecha-
nisms in place an additional level of security against self-targeting
of the host genome could be warranted. The requirement for a
more stringent protection against self-targeting could be related to
the constitutive gene expression of the Type I-F in E. coli LF82
[43], whereas the expression of the Type I-E system of E. coli K12
is repressed under laboratory growth conditions [57,58,59].
The distinct mechanisms of self versus non-self discrimination of
Type III-A and target versus non-target recognition of Type I-E
have implications for the route that invaders can take to escape
CRISPR-interference. While both systems can be evaded by
making point mutations in the protospacer [41,60], only the Type
I-E system can be evaded by mutations outside the protospacer,
specifically in the region containing the PAM. In contrast, escape
from Type III-A interference through mutations outside the
protospacer seems rather unlikely, as it would typically require
three mutations to establish base pairing between the 59 handle
and the protospacer flank [36].
Materials and Methods
Bacterial strains, gene cloning, plasmids and vectors
E. coli BL21 (DE3) strains were used for Cascade purification.
Novablue (DE3) cells supplemented with CRISPR plasmid and
plasmids expressing cas genes and engineered K12 strains with cas
genes fused to inducible promoters were used for phage sensitivity
tests and transformation assays. A description of the plasmids and
the strains used in this study can be found in the Supplementary
Information (Table S1).
Protein expression and purification
Wildtype M13-Cascade was expressed in E. coli BL21 (DE3) and
purified as described before [29], from pWUR408, pWUR514
and pWUR615 (Table S1). g8G-1T-Cascade, g8C-2A-Cascade, g8C-
3G-Cascade, were expressed from pWUR408, pWUR514 and
either pWUR680, pWUR682, or pWUR684, respectively (Table
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S1). pWUR680, pWUR682, and pWUR684 were generated by
subcloning a synthetic CRISPR (Table S3 and Table S4, Geneart)
into pACYC using EcoNI and Acc65I restriction sites. Although
BL21 (DE3) contains genomic CRISPR loci, previous analyses by
Mass Spectrometry have demonstrated that these expression and
purification conditions yield homogeneous Cascade complexes
loaded with crRNA species from the overexpression plasmids, and
not from the chromosme [22].
Figure 5. Model of self versus non-self discrimination by Type III-A systems and target versus non-target discrimination by Type I-E
systems. A) Model of the mechanism employed by Type III-A systems. Type III-A systems presumably target DNA through R-loop formation. The
crRNA (here depicted as the 37 nt species) could be part of a ribonucleoprotein complex consisting of Cas proteins and a single crRNA (Csm
complex). R-loop formation and subsequent interference is inhibited when base pairing occurs between the 22, 23 and 24 positions of the repeat
sequence at the 59 end of the crRNA and the sequence flanking the 39 end of the protospacer. How this base pairing is monitored is currently
unknown, but it might involve a Cas protein. B) Model of target versus non-target discrimination by Type I-E systems. Type I-E systems target DNA
through R-loop formation. The 61 nt crRNA is part of the Cascade ribonucleoprotein complex. R-loop formation and subsequent Cas3-mediated
cleavage of the target DNA are activated when a PAM is present at the 21, 22 and 23 positions, in the sequence flanking the 39 end of the
protospacer. The presence of a PAM is monitored through the Cse1 subunit.
doi:10.1371/journal.pgen.1003742.g005
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Gel electrophoresis
Purified Cascade was separated on a 12% SDS-PAGE as
described before [22], and stained using Coomassie Blue overnight,
followed by destaining in Millipore water. Nucleic acids were
isolated from purified Cascade complexes using an extraction with
phenol:chloroform:isoamylalcohol (25:24:1) equilibrated at pH 8.0
(Fluka) and separated on a 6M urea 15% acrylamide gel, as
described in [22], followed by staining with SybR safe (Invitrogen)
in a 1:10000 dilution in TAE for 30 minutes. Electrophoretic
Mobility Shift Assays were performed as in [29], using the PAGE-
purified oligonucleotides listed in Table S2, which were annealed
and 59-labeled with 32P c-ATP (PerkinElmer) using T4 polynucle-
otide kinase (Fermentas). Determining the Kd of the Cascade target
DNA interaction was performed as described in [41]. Briefly, the
signals of unbound and bound probe were quantified using
Quantity One software (Bio-Rad). The fraction of bound probe
was plotted against the total Cascade concentration, and the data
fitted by nonlinear regression analysis to the following equation:
Fraction bound probe= [Cascade]total/(Kd+[Cascade]total).
Phage M13 mutagenesis
Mutations of PAM sequence preceding the g8 protospacer were
introduced into the M13 phage genome by QuickChange Site-
Directed Mutagenesis Kit (Stratagene) as described previously
([41]).
CRISPR repeat mutagenesis
Repeat mutant library was generated by QuikChange Site-
Directed Mutagenesis Kit (Stratagene) according to manufactur-
er’s protocol. The g8 CRISPR cassette plasmid targeting the M13
phage gene 8 (pWUR477-g8, described in [41]) was used as
template. Mutations were introduced at positions 23, 22, or 21
of the repeat preceding the g8 spacer.
Phage infection studies
Cells sensitivity to wildtype and mutant M13 phages was
determined by a spot test method as described [41] or using
standard plaquing assay. Efficiency of plaquing was calculated as a
ratio of the plaque number formed on a lawn of tested cells to the
number of plaques on sensitive (non-targeting) cell lawn.
Transformation assay
K12 strains with cas genes fused to inducible promoters and g8
spacer in CRISPR were transformed with 10 ng of plasmid DNA
by electroporation. Transformation efficiency was determined as
colony forming units for transformants of targeting strain BW40119
(Table S1) per mg DNA. Plasmids containing the g8 protospacer and
PAM mutants were ordered synthetically at Geneart, Germany.
Supporting Information
Figure S1 Shows the original EMSAs belonging to Figure 1.
From left to right, lanes contain 600, 250, 120, 60, 25, 12.5, 6, 2.5,
and 0 nM Cascade.
(TIF)
Figure S2 A) and B) show the original EMSAs belonging to
Figure 2. From left to right, lanes contain 600, 250, 120, 60, 25,
12.5, 6, 2.5, and 0 nM Cascade.
(TIF)
Figure S3 A) and B) show the original EMSAs belonging to
Figure 3. From left to right, lanes contain 600, 250, 120, 60, 25,
12.5, 6, 2.5, and 0 nM Cascade.
(TIF)
Figure S4 A) Coomassie stained SDS-PAGE of theWT andmutant
g8-Cascade complexes shows that all complexes are formed with a
correct stoichiometry.B) Nucleic acids bound to each of the g8-Cascade
complexes shows that intact crRNA is present in all complexes.
(TIF)
Figure S5 Base pairing potential between the PAM mutants and
the g8 CRISPR repeat mutants shown in Figure 4. A selection of the
data shown in Figure 3 is shown, lacking the repeat/non-allowed
PAM combinations. The repeat/allowed PAM combinations are
highlighted that would give rise to a base pairing pattern
corresponding to that observed for the resistant phenotype, but
that do not give rise to CRISPR-interference. This suggests that in
these cases the repeat sequence is interferes with CRISPR immunity
rather than that a correlation exists with base pairing potential.
(TIF)
Figure S6 Cells sensitivity to wildtype and mutant M13 phages
was determined using standard plaquing assay. Repeat mutations
were introduced into the genomic CRISPR cassette in an
engineered M13 targeting E. coli strain with cas genes fused to
the inducible promoters [11]. Efficiency of plaquing was calculated
as a ratio of the plaque number formed on a lawn of tested cells to
the number of plaques on sensitive (nontargeting) cell lawn.
(TIF)
Figure S7 Efficiency of transformation of E. coli expressing
Cascade, g8-crRNA and Cas3 with pG8 plasmid variants carrying
the g8 protospacer flanked by 26 different PAM variants. Efficiency
of transformation was calculated as the number of transformants per
microgram DNA. Plasmid pUC19 serves as a negative control. The
CGG PAM (indicated with #) corresponds to the repeat sequence
flanking a spacer in the CRISPR array. The four PAM sequences
that provide a phage resistant phenotype are indicated with an
asterisk (*). The TTT PAM provides resistance against plasmid
transformation, but not against phage infection.
(TIF)
Table S1 Putative basepairing between PAM and crRNA 59 or
39 handles in various subtypes.
(DOC)
Table S2 Plasmids and strains used in this study.
(DOC)
Table S3 Oligo’s used in this study.
(DOC)
Table S4 Synthetic CRISPR sequences used in this study.
(DOC)
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